| JHLD-2513 | JHLD-2516 | JHLD-2519 | JHLD-2522 | JHLD-2528 | JHLD-2538 |
| JHLD-2533 | JHLD-2713 | JHLD-2716 | JHLD-2719 | JHLD-2722 | JHLD-2728 |
| JHLD-2738 | JHLD-2733 | JHLD-3013 | JHLD-3016 | JHLD-3019 | JHLD-3022 |
| JHLD-3028 | JHLD-3038 | JHLD-3033 | JHLD-3513 | JHLD-3516 | JHLD-3519 |
| JHLD-3522 | JHLD-3528 | JHLD-3538 | JHLD-3533 | JHLD-4013 | JHLD-4016 |
| JHLD-4019 | JHLD-4022 | JHLD-4028 | JHLD-4038 | JHLD-4033 |
· The drug stent system is intended to be implanted into the coronary artery stenosis site of the human body through the femoral artery or radial artery to support the vascular wall and treat coronary artery stenosis. The stent is externally attached to the vascular wall and the drugs coated thereon can be released to prevent the proliferation of vascular smooth muscle cells and intima tissue, thus avoiding vascular restenosis.
